Tomography

Global Industrial Computed Tomography Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Friday, July 30, 2021 - 11:34am

The "Industrial Computed Tomography Market Size, Share & Trends Analysis Report by Offering (Equipment, Services), by Vertical (Oil & Gas, Electronics), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Industrial Computed Tomography Market Size, Share & Trends Analysis Report by Offering (Equipment, Services), by Vertical (Oil & Gas, Electronics), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028.
  • Industrial computed tomography systems are increasingly being used for inspecting and testing the internal and external structure & design of various complex parts and components without destructing/disassembling the product.
  • Furthermore, assembly analysis is increasingly being done using the industrial computed tomography systems in the automotive industry that does not require the assembled systems to be disassembled for inspection.

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Tuesday, July 27, 2021 - 3:30pm

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Tuesday, July 27, 2021 - 3:30pm

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.

Worldwide Computed Tomography Growth Opportunities to 2025 - COVID-19 Resulted in Postponement of Elective Surgeries

Friday, July 23, 2021 - 1:30pm

DUBLIN, July 23, 2021 /PRNewswire/ -- The "Global Computed Tomography Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 23, 2021 /PRNewswire/ -- The "Global Computed Tomography Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%-4%.
  • The dynamic CT industry involves many participants introducing technological innovations frequently to match the rapidly evolving needs of clinicians, radiologists, and technologists.
  • The COVID-19 pandemic further resulted in the postponement of elective surgeries, which took a toll on patient footfall in radiology and affected CT modality.

Global Diagnostic/Medical Imaging Market (2020 to 2026) - Featuring Fujifilm Visual Sonics, Siemens Healthineers and PerkinElmer Among Others - ResearchAndMarkets.com

Thursday, July 22, 2021 - 5:21pm

Globally, Medical imaging is used to diagnose and treat disease and expose internal structures concealed by the skin and bones.

Key Points: 
  • Globally, Medical imaging is used to diagnose and treat disease and expose internal structures concealed by the skin and bones.
  • Global Diagnostic Imaging Market primarily focuses on creating images of the body, organs, and other internal structures, providing products like X-ray Devices, Computed Tomography, MRI equipment, Ultrasound, and Nuclear Imaging (PET / SPECT) Systems.
  • The COVID-19 pandemic, which occurred in the first days of 2020, has had a significant impact on the Global Diagnostic Imaging Market.
  • High cost of equipment, increasing regulatory burden and declining reimbursement, limitations associated with standalone systems are some reasons restricting the Global Diagnostic Imaging Market.

MeVX™ High Energy Computed Tomography X-Ray Solutions

Thursday, July 15, 2021 - 4:00pm

ROGERS, Minn., July 15, 2021 /PRNewswire/ -- North Star Imaging introduces a new range of High Energy X-ray systems that are available in 3, 6 and 9 Million Electron Volts.

Key Points: 
  • ROGERS, Minn., July 15, 2021 /PRNewswire/ -- North Star Imaging introduces a new range of High Energy X-ray systems that are available in 3, 6 and 9 Million Electron Volts.
  • Timothy Lebens, Global Sales Director NSI says: "The MeVX line answers the need for higher energy X-ray inspection to deeply penetrate, dense parts, that cannot be scanned using standard, lower energy, X-ray equipment.
  • Use of a 3, 6 or a 9 MeVX is a huge time saving solution, especially for aerospace, defense, automotive and other emerging technologies where speed and superior, high resolution images are required for mission critical parts."
  • North Star Imaging manufactures industrial 2D Digital Radiography, 3D Computed Tomography (CT) and High Energy X-ray equipment and provides as-needed X-ray Inspection services.

NeuroLogica Announces a Research Collaboration with Massachusetts General Hospital to Pilot Photon Counting Computed Tomography at the Patient’s Point-Of-Care Using OmniTom Elite CT

Tuesday, July 13, 2021 - 2:00pm

NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.

Key Points: 
  • NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.
  • View the full release here: https://www.businesswire.com/news/home/20210713005323/en/
    NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care.
  • Pending FDA 510(k) clearance of this technology, Massachusetts General Hospital will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.
  • "We are excited about our collaboration with NeuroLogica, said Raj Gupta, MD, PhD, Director, Ultra-High-Resolution Volume CT Lab, Massachusetts General Hospital.

Industrial Computed Tomography Market Size Worth $765.8 Million By 2028: Grand View Research, Inc.

Monday, July 12, 2021 - 10:05am

SAN FRANCISCO, July 12, 2021 /PRNewswire/ --The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, July 12, 2021 /PRNewswire/ --The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • Moreover, a rise in the demand for advanced electronics is expected to support market growth.
  • Industrial computed tomography systems are increasingly being used for inspecting and testing the internal and external structure & design of various complex parts and components without destructing/disassembling the product.
  • Grand View Research has segmented the global industrial computed tomography market on the basis of offering, application, vertical, and region:
    Industrial CT Offering Outlook (Revenue, USD Million, 2017 - 2028)

Industrial Computed Tomography Market Size Worth $765.8 Million By 2028: Grand View Research, Inc.

Monday, July 12, 2021 - 10:05am

SAN FRANCISCO, July 12, 2021 /PRNewswire/ --The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, July 12, 2021 /PRNewswire/ --The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028, according to a new report by Grand View Research, Inc.
  • Moreover, a rise in the demand for advanced electronics is expected to support market growth.
  • Industrial computed tomography systems are increasingly being used for inspecting and testing the internal and external structure & design of various complex parts and components without destructing/disassembling the product.
  • Grand View Research has segmented the global industrial computed tomography market on the basis of offering, application, vertical, and region:
    Industrial CT Offering Outlook (Revenue, USD Million, 2017 - 2028)

NCCN Maintains Qualification as CMS-Approved Provider-Led Entity for the Development of Imaging Appropriate Use Criteria

Wednesday, July 7, 2021 - 2:37pm

NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) are accessible for free to registered users of NCCN.org through an easy-to-use database at NCCN.org/ImagingAUC .

Key Points: 
  • NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) are accessible for free to registered users of NCCN.org through an easy-to-use database at NCCN.org/ImagingAUC .
  • "NCCN is honored to remain among the distinguished group of CMS-approved provider-led entities for development of diagnostic imaging AUC," said Robert W. Carlson, MD, Chief Executive Officer, NCCN.
  • NCCN Imaging AUC are based directly on the NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ) and include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance.
  • All imaging procedures recommended in the NCCN Guidelines, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT) and ultrasound, are included within NCCN Imaging AUC.